Eastman Chemical's (EMN) Sell (D+) Rating Reaffirmed at Weiss Ratings

Key Points

• Eastman Chemical's stock received a "sell (D+)" rating from Weiss Ratings, indicating a cautious outlook from analysts.
• Multiple analysts have conflicting views, with Citigroup raising its price target to $70 and maintaining a "buy" rating, while Goldman Sachs lowered its target to $65 and set a "neutral" rating.
• The stock is trading at approximately $62.32, with a consensus rating of "Moderate Buy" and an average price target of $85.54.

Eastman Chemical (NYSE:EMN - Get Free Report)'s stock had its "sell (d+)" rating reiterated by Weiss Ratings in a note issued to investors on Wednesday,Weiss Ratings reports.

EMN has been the topic of a number of other reports. Citigroup upped their price target on shares of Eastman Chemical from $68.00 to $70.00 and gave the stock a "buy" rating in a research note on Thursday, October 2nd. Wells Fargo & Company raised their price target on shares of Eastman Chemical from $70.00 to $80.00 and gave the company an "overweight" rating in a report on Tuesday, September 16th. The Goldman Sachs Group cut their price objective on shares of Eastman Chemical from $87.00 to $65.00 and set a "neutral" rating on the stock in a research report on Thursday, August 7th. KeyCorp set a $79.00 price target on shares of Eastman Chemical and gave the stock an "overweight" rating in a research report on Monday, August 4th. Finally, Royal Bank Of Canada lowered their price target on shares of Eastman Chemical from $91.00 to $74.00 and set an "outperform" rating on the stock in a report on Tuesday, August 5th. Eight analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $85.54.

Eastman Chemical Trading Down 0.0%

Eastman Chemical stock traded down $0.03 during midday trading on Wednesday, reaching $62.32. The stock had a trading volume of 981,016 shares, compared to its average volume of 1,591,141. Eastman Chemical has a twelve month low of $56.78 and a twelve month high of $111.79. The stock has a market capitalization of $7.16 billion, a PE ratio of 8.75, a price-to-earnings-growth ratio of 6.21 and a beta of 1.29. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.78 and a current ratio of 1.68. The stock's 50-day simple moving average is $65.41 and its 200 day simple moving average is $74.40.

Eastman Chemical (NYSE:EMN - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The basic materials company reported $1.60 earnings per share for the quarter, missing the consensus estimate of $1.72 by ($0.12). The firm had revenue of $2.29 billion during the quarter, compared to the consensus estimate of $2.32 billion. Eastman Chemical had a net margin of 8.96% and a return on equity of 15.24%. The firm's quarterly revenue was down 3.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.15 earnings per share. Eastman Chemical has set its Q3 2025 guidance at 1.250-1.250 EPS. Analysts expect that Eastman Chemical will post 8.55 EPS for the current year.

Hedge Funds Weigh In On Eastman Chemical

A number of hedge funds have recently modified their holdings of EMN. Norges Bank bought a new stake in shares of Eastman Chemical during the 2nd quarter valued at about $121,060,000. Qube Research & Technologies Ltd boosted its stake in shares of Eastman Chemical by 1,456.4% during the 2nd quarter. Qube Research & Technologies Ltd now owns 708,290 shares of the basic materials company's stock valued at $52,881,000 after purchasing an additional 662,783 shares in the last quarter. Ilex Capital Partners UK LLP bought a new stake in shares of Eastman Chemical during the 2nd quarter valued at about $42,547,000. Miller Howard Investments Inc. NY bought a new stake in shares of Eastman Chemical during the 2nd quarter valued at about $26,212,000. Finally, Nuveen LLC bought a new stake in Eastman Chemical during the first quarter worth about $26,289,000. Hedge funds and other institutional investors own 83.65% of the company's stock.

About Eastman Chemical

Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.